rs121909491
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The ENST00000373474.9(LMX1B):c.668G>A(p.Arg223Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R223P) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000373474.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LMX1B | NM_001174147.2 | c.668G>A | p.Arg223Gln | missense_variant | 4/8 | ENST00000373474.9 | NP_001167618.1 | |
LMX1B | NM_001174146.2 | c.668G>A | p.Arg223Gln | missense_variant | 4/8 | NP_001167617.1 | ||
LMX1B | NM_002316.4 | c.668G>A | p.Arg223Gln | missense_variant | 4/8 | NP_002307.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LMX1B | ENST00000373474.9 | c.668G>A | p.Arg223Gln | missense_variant | 4/8 | 1 | NM_001174147.2 | ENSP00000362573 | P4 | |
LMX1B | ENST00000355497.10 | c.668G>A | p.Arg223Gln | missense_variant | 4/8 | 1 | ENSP00000347684 | |||
LMX1B | ENST00000526117.6 | c.668G>A | p.Arg223Gln | missense_variant | 4/8 | 1 | ENSP00000436930 | A1 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1459266Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 725750
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | May 10, 2022 | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Not observed in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 9837817, 25898926, 29869118, 28780565, 30647093, 32457516, 32604935) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 04, 2023 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 223 of the LMX1B protein (p.Arg223Gln). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with LMX1B-related conditions (PMID: 9837817, 28780565, 29869118). In at least one individual the variant was observed to be de novo. This variant is also known as c.599G>A, p.Arg200Gln. ClinVar contains an entry for this variant (Variation ID: 7007). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt LMX1B protein function. Experimental studies have shown that this missense change affects LMX1B function (PMID: 9837817). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2023 | LMX1B: PM1, PM2, PM5, PS2:Moderate, PP3, PS3:Supporting - |
Nail-patella syndrome Pathogenic:3
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 01, 1998 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Pediatric Nephrology Laboratory, The University of Tokyo Hospital | Mar 16, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Kasturba Medical College, Manipal, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India | - | - - |
LMX1B-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 12, 2024 | The LMX1B c.668G>A variant is predicted to result in the amino acid substitution p.Arg223Gln. This variant has been reported in multiple unrelated families to be pathogenic for nail-patella syndrome (reported as R200Q/G599A in McIntosh et al. 1998. PubMed ID: 9837817; Bezdíčka et al. 2018. PubMed ID: 29869118; Sen et al. 2017. PubMed ID: 28780565). This variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at